2023 , MND, K9 Cancer Commercial Deal , Covid , Human Cancer, OHD, page-81

First 81 Last

Share
Profile

Follow
NZ Trader

12,319 Posts.

6325

13/12/22

15:05

Post #: 65294575
Share

A Rabbit would be easy,,,,

Originally posted by Jockthegreat: ↑

Close to 0 chance if you try work backwards on timelines of known paths.

Canine - Still to recruit and test 21 dogs at last comms. We know that will likely take at least 6 months if we are lucky. Then there is analysis, more actual discussions (not Rogers 'ongoing discussions') and negotiations. Realistically based on recruitment rates historically, maybe a hint of a dog deal end of 2023. Unless we manage to convince someone to cough up cash prior to completion of phase 2....but if they arent already convinced then why would they not wait until those results come out.

MND - Many more months of escalating dose protocols. Then reviewing the data. Then negotiating whether to proceed to phase 2. Then designing phase 2. Likely phase 2 commences in early 2024. Then phase 2 will take all 2024.

Others - not even on the radar.

So, unless they pull the rabbit out of the hat, there appear to be no massive inflection points between now and end of 2023. A successful MND phase 1 won't shift the dial much. I'm actually beginning to wonder if the 'reward' options were a ploy to raise a quick 700k. I'd be interested to know their reasoning for picking the option strike price. Did they actually believe it'd be there, and based on what...if they based it on their ability to drive the SP they are sadly delusional.

Expand

Last edited by NZ Trader: 13/12/22

PAA Price at posting: 6.9¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

KAU

Kaiser Reef sets up $8M capital raising to boost expansion at A1 gold mine

WTC

A sex scandal is unlikely to hurt Australia's tech crown jewel – just look at trades

Superannuation Essentials: Building Wealth for Your Retirement

BTH

Bigtincan bounces 9% after $409M merger proposal sets stage for Nasdaq listing

There are more pages in this discussion • 73 more messages in this thread...

First 81 Last

Add NUZ (ASX) to my watchlist

(20min delay)
Last 22.5¢		Change 0.000(0.00%)		Mkt cap ! $109.4M

Open	High	Low	Value	Volume
23.0¢	23.5¢	22.5¢	$196.0K	858.9K

Buyers (Bids)

No.	Vol.	Price($)
1	134795	22.5¢

Sellers (Offers)

Price($)	Vol.	No.
23.0¢	50660	1

View Market Depth

No.	Vol.	Price($)
1	134795	0.225
9	490119	0.220
2	26627	0.215
3	15765	0.210
3	103125	0.205

Price($)	Vol.	No.
0.235	611681	2
0.240	20367	1
0.245	339236	4
0.250	306054	5
0.255	8641	1

Last trade - 16.10pm 21/10/2024 (20 minute delay)

NUZ (ASX) Chart

2023 , MND, K9 Cancer Commercial Deal , Covid , Human Cancer, OHD, page-81

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Kaiser Reef sets up $8M capital raising to boost expansion at A1 gold mine

A sex scandal is unlikely to hurt Australia's tech crown jewel – just look at trades

Superannuation Essentials: Building Wealth for Your Retirement

Bigtincan bounces 9% after $409M merger proposal sets stage for Nasdaq listing

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

2023 , MND, K9 Cancer Commercial Deal , Covid , Human Cancer, OHD, page-81

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Kaiser Reef sets up $8M capital raising to boost expansion at A1 gold mine

A sex scandal is unlikely to hurt Australia's tech crown jewel – just look at trades

Superannuation Essentials: Building Wealth for Your Retirement

Bigtincan bounces 9% after $409M merger proposal sets stage for Nasdaq listing

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News